Barclays
INFU icon

Barclays’s InfuSystem Holdings INFU Stock Holding History

Barclays’s Portfolio INFU Stock Details INFU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$215K Sell
23,286
-2,026
-8% -$17.7K ﹤0.01% 3648
2025
Q4 		$227K Buy
25,312
+13,207
+109% +$126K ﹤0.01% 4248
2025
Q3 		$125K Sell
12,105
-2,289
-16% -$19K ﹤0.01% 4543
2025
Q2 		$89.8K Sell
14,394
-14,583
-50% -$80.6K ﹤0.01% 4607
2025
Q1 		$156K Sell
28,977
-2,502
-8% -$18.3K ﹤0.01% 4176
2024
Q4 		$266K Buy
31,479
+2,882
+10% +$22.7K ﹤0.01% 4171
2024
Q3 		$192K Buy
28,597
+21,457
+301% +$139K ﹤0.01% 4323
2024
Q2 		$48.8K Sell
7,140
-6,074
-46% -$44.6K ﹤0.01% 4220
2024
Q1 		$113K Sell
13,214
-12,424
-48% -$117K ﹤0.01% 4388
2023
Q4 		$270K Buy
25,638
+21,706
+552% +$213K ﹤0.01% 4275
2023
Q3 		$37.9K Buy
3,932
+279
+8% +$2.85K ﹤0.01% 3976
2023
Q2 		$35.2K Buy
+3,653
New +$33.1K ﹤0.01% 3981
2022
Q2 		– Sell
-2,943
Closed -$29K – 5141
2022
Q1 		$29K Sell
2,943
-19,038
-87% -$245K ﹤0.01% 4312
2021
Q4 		$374K Buy
21,981
+14,579
+197% +$231K ﹤0.01% 3324
2021
Q3 		$97K Buy
7,402
+1,071
+17% +$17.5K ﹤0.01% 3909
2021
Q2 		$131K Sell
6,331
-10,160
-62% -$205K ﹤0.01% 3737
2021
Q1 		$336K Buy
16,491
+2,833
+21% +$53.1K ﹤0.01% 3435
2020
Q4 		$257K Sell
13,658
-1,880
-12% -$28.3K ﹤0.01% 3623
2020
Q3 		$200K Sell
15,538
-1,317
-8% -$17.1K ﹤0.01% 3848
2020
Q2 		$194K Buy
+16,855
New +$194K ﹤0.01% 4088
2019
Q4 		– Sell
-43
Closed – – 6559
2019
Q3 		$0 Buy
+43
New +$208 ﹤0.01% 6899
2019
Q2 		– Sell
-121
Closed -$1K – 7077
2019
Q1 		$1K Buy
+121
New +$482 ﹤0.01% 6914
2018
Q4 		– Sell
-53
Closed – – 7114
2018
Q3 		$0 Buy
+53
New +$173 ﹤0.01% 7242
2018
Q2 		– Sell
-6
Closed – – 7094
2018
Q1 		$0 Buy
+6
New +$14 ﹤0.01% 7179

Other funds holding INFU

MA
Minerva Advisors Bala Cynwyd, Pennsylvania $155M AUM 35.49% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PAIM
Punch & Associates Investment Management Edina, Minnesota $1.73B AUM 27.65% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Barclays's INFU Position: Q1 2026 in Review

Barclays reduced its InfuSystem Holdings (INFU) stake by 8% in Q1 2026, selling an estimated $17.7K and leaving 23,286 shares worth $215K. The position accounts for ﹤0.01% of the portfolio, ranked #3648.

Barclays first reported a position in INFU in Q1 2018 and has held it in 24 quarters since. The position peaked at $374K in Q4 2021. 96 funds tracked by Wall St. Rank hold INFU as of Q1 2026.

  • Barclays held 23,286 shares of InfuSystem Holdings worth $215K as of Q1 2026.
  • Barclays sold 2,026 InfuSystem Holdings shares in Q1 2026, an estimated $17.7K.
  • InfuSystem Holdings made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #3648 holding.
  • Barclays first reported a position in InfuSystem Holdings in Q1 2018 and has held it in 24 quarters since.
  • Barclays's InfuSystem Holdings position peaked at $374K in Q4 2021.
  • 96 funds tracked by Wall St. Rank held InfuSystem Holdings as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.